Videos

CPT code updates in 2026 will change how interventional cardiologists get paid
A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.
Reimbursement for AI-based plaque assessments is improving
A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen.
Adjustable interatrial shunt for heart failure shows promise in first-in-human trial
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.
Canon gains FDA clearance for new ultrasound processing algorithms ahead of RSNA
The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.
Canon introduces new combined CT-angiography interventional system
Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains the technology behind a new combined CT angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA clearance.

Arnold Seto, MD, MPA, FACC, FSCAI, cath lab director, Long Beach VA Medical Center, professor of medicine at Charles Drew University, Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and chair of the SCAI Advocacy Committee, explains the new CPT reimbursement codes being introduced in January 2026 and their impact on practice.

CPT code updates in 2026 will change how interventional cardiologists get paid

A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.

The Society of Cardiovascular Computed Tomography (SCCT) is seeing major progress in its long-running push to secure broad reimbursement for artificial intelligence (AI)-enabled coronary CT angiography (CCTA) plaque analysis. According to Roosha Parikh, MD, FACC, FSCCT, associate director of Cardiac CT at St. Francis Heart Hospital, Long Island, New York, and a member of the SCCT Health Policy and Practice Committee, both Medicare and a growing number of private insurers are now covering the technology.

Reimbursement for AI-based plaque assessments is improving

A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen.

Gregg W. Stone, MD, Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology) and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, discusses the ATHENS-HF Trial, a first-in-man study of a chronically-adjustbable, bi-atrial pressure sensing inter-atrial shunt from Adona Medical.

Adjustable interatrial shunt for heart failure shows promise in first-in-human trial

Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.

Caon Medical USA ultrasound director Dan Skyba explains advances in ultrasound processing algorithms at RSNA 2025.

Canon gains FDA clearance for new ultrasound processing algorithms ahead of RSNA

The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.

Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains a new combined CT-angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA approval. The Alphenix 4D CT Insight Edition includes numerous radiation dose lowering technologies.

Canon introduces new combined CT-angiography interventional system

Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains the technology behind a new combined CT angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA clearance.

Canon Medical is launching new X-ray advances at the Radiological Society of North America (RSNA) 2025 annual meeting. This includes the advanced artificial intelligence Clear-IQ technology to boost diagnostic image quality of low-dose images, and the new Adora DRFi low-dose fluoroscopy system. Canon will also highlight the patented technology built into its premium mobile X-ray solution, the SOLTUS 500.

Canon shows new X-ray imaging advances at RSNA 2025

Sponsored by Canon Medical Systems USA, Inc.

Canon Medical is launching new X-ray advances at the Radiological Society of North America (RSNA) 2025 annual meeting.

Society of Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, professor of medicine at New York Medical College, explains the SCAI initiative to improve outcomes in cardiogenic shock by monitoring and lowering patient lactate levels.

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels

SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data.

SCAI President Srihari S. Naidu, MD, professor of medicine at New York Medical College, explained some of the key payment issues interventional cardiologists are facing amid declining Medicare reimbursements.

SCAI fighting for interventional cardiologists amid challenging payment policies

SCAI President Srihari Naidu, MD, detailed some of the challenges interventional cardiologists face as reimbursements keep declining. The group has been building new partnerships with other medical societies to strengthen its influence in Washington.